In the case of lymph node metastasis (Figure 7B) and distant metastasis (Figure 7C), as well as the grading of histological malignancy (Figure 7D), our study showed no statistical differences in the methylation status of the IL-6 promoter between analysed subgroups. Here, IL6 is linked to metastatic malignant neoplasm in the lymph nodes.